Logo

    Description

    Erythromycin Estolate IP BP USP is a high-quality macrolide antibiotic manufactured to meet international pharmacopeial standards including IP, BP, and USP. It is specifically designed to treat a wide range of bacterial infections affecting critical areas such as eyes, respiratory tract, and urinary systems. This antibiotic is particularly beneficial for patients who are allergic or sensitive to penicillin or sulfa drugs, offering a reliable alternative with proven efficacy. With CAS number 3521-62-8, it ensures precise identification and quality assurance for pharmaceutical manufacturers and distributors seeking trustworthy antibiotic ingredients. This product is extensively utilized across the pharmaceutical industry for formulating oral suspensions, tablets, and other dosage forms aimed at combating bacterial infections. Hospitals, clinics, and healthcare providers depend on Erythromycin Estolate for treating conditions like pharyngitis, pneumonia, bronchitis, and various skin infec...
    Erythromycin Estolate IP BP USP is a high-quality macrolide antibiotic manufactured to meet international pharmacopeial standards including IP, BP, and USP. It is specifically designed to treat a wide range of bacterial infections affecting critical areas such as eyes, respiratory tract, and urinary systems. This antibiotic is particularly beneficial for patients who are allergic or sensitive to penicillin or sulfa drugs, offering a reliable alternative with proven efficacy. With CAS number 3521-62-8, it ensures precise identification and quality assurance for pharmaceutical manufacturers and distributors seeking trustworthy antibiotic ingredients.
    
    This product is extensively utilized across the pharmaceutical industry for formulating oral suspensions, tablets, and other dosage forms aimed at combating bacterial infections. Hospitals, clinics, and healthcare providers depend on Erythromycin Estolate for treating conditions like pharyngitis, pneumonia, bronchitis, and various skin infections. It serves as a critical component in antimicrobial therapy within both public health systems and private healthcare networks, ensuring patient safety and treatment effectiveness across diverse medical settings.
    
    Erythromycin Estolate delivers significant value through its consistent quality and reliability, meeting the specific requirements of pharmaceutical partners. Its broad-spectrum antibacterial action reduces treatment duration and enhances patient outcomes, supporting healthcare efficiency. The product's adherence to IP, BP, and USP standards guarantees consistency and safety, minimizing risks for manufacturers and end-users. This reliability builds trust among suppliers and distributors, fostering long-term partnerships in competitive pharmaceutical markets.
    
    Key Features:
    - Complies with IP, BP, and USP pharmacopeial standards
    - Broad-spectrum antibiotic effective against various bacterial infections
    - Suitable for patients allergic to penicillin or sulfa drugs
    - CAS number 3521-62-8 for precise identification and quality control
    - Manufactured under strict quality assurance protocols
    
    Benefits:
    - Provides reliable alternative for penicillin-allergic patients
    - Ensures consistent therapeutic outcomes across infections
    - Supports healthcare efficiency with proven efficacy
    - Maintains strict quality control for safety assurance
    - Builds trust through international standard compliance

    Specifications

    Additional Information
    Country of OriginIndia
    CustomisableNo

    Application

    Erythromycin Estolate is widely used in pharmaceutical formulations for treating bacterial infections affecting eyes, respiratory tract, and urinary systems. Its broad-spectrum efficacy makes it a preferred choice for healthcare providers managing common bacterial conditions, especially where penicillin or sulfa drugs are not suitable due to patient allergies or sensitivities. This antibiotic is essential in clinical settings for various infections and is formulated under strict IP, BP, and USP standards to ensure safety and effectiveness. It provides a reliable alternative for patients requiring different antibiotic therapies, supporting consistent treatment outcomes across multiple healthcare environments with trusted quality. - Treatment of bacterial conjunctivitis and eye infections - Management of streptococcal pharyngitis and tonsillitis - Therapy for community-acquired pneumonia and bronchitis - Addressing skin and soft tissue bacterial infections - Urinary tract infection treatment in clinical care

    Trade Details

    Available StockIn Stock
    Sample AvailabilityNo

    Payment Terms

    Payment Terms
    • Cash on Delivery (COD, if applicable)

    Company Profile

    Mehta Pharmaceutical Industries, Maharashtra
    TruBasic
    IndiaMaharashtra, India
    ManufacturerImporter / Exporter
    Factory Details
    Factory SizeBelow 1000 sqm
    Annual Production Capacity0

    Erythromycin Estolate IP BP USP Antibiotic For Bacterial Infections

    Erythromycin Estolate IP BP USP is a macrolide antibiotic for treating bacterial infections in eyes, respiratory tract, and urinary systems. Ideal for penicillin-allergic patients with reliable therapeutic outcomes.
    Min. Order Quantity: 1 unit

    Shipping

    Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

    Mehta Pharmaceutical Industries
    Verified
    IndiaMaharashtra, India
    ManufacturerImporter / Exporter

    More Products From Supplier